Trial Profile
Evaluation of 18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 30 Nov 2023
Price :
$35
*
At a glance
- Drugs Piflufolastat F18 (Primary) ; Fludeoxyglucose F-18; Sodium fluoride
- Indications Prostate cancer
- Focus Diagnostic use
- 28 Nov 2023 Planned End Date changed from 30 Jun 2025 to 30 Jun 2027.
- 28 Nov 2023 Planned primary completion date changed from 31 Dec 2023 to 31 Dec 2025.
- 21 Jan 2022 Planned primary completion date changed from 30 Dec 2022 to 31 Dec 2023.